Biofrontera AG (ETR:B8FK)
Germany · Delayed Price · Currency is EUR 2.390
+0.040 (1.70%)
Jun 19, 2026, 5:35 PM CET
Biofrontera AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 13.63 | 13.19 | 12.18 | 32.25 | 25.74 | 28.79 |
Other Revenue | - | - | - | -0 | - | - |
| 13.63 | 13.19 | 12.18 | 32.25 | 25.74 | 28.79 | |
Revenue Growth (YoY) | 11.87% | 8.26% | -62.22% | 25.29% | -10.59% | -5.14% |
Cost of Revenue | 2.4 | 2.28 | 2.07 | 6.24 | 4.76 | 3.91 |
Gross Profit | 11.23 | 10.91 | 10.12 | 26.01 | 20.98 | 24.87 |
Selling, General & Admin | 9.82 | 9.7 | 9.5 | 13.38 | 12.26 | 33.75 |
Research & Development | 2.22 | 2.23 | 2.2 | 7.85 | 7.13 | 7.01 |
Operating Expenses | 12.03 | 11.93 | 11.7 | 21.22 | 19.39 | 40.76 |
Operating Income | -0.8 | -1.03 | -1.59 | 4.78 | 1.59 | -15.88 |
Interest Expense | -0.02 | -0.01 | -0.01 | -0.02 | -0.16 | -3.72 |
Interest & Investment Income | - | - | 0.07 | 0.02 | 0 | 0.01 |
Earnings From Equity Investments | - | - | - | -7.26 | -44.17 | 14.73 |
Currency Exchange Gain (Loss) | - | - | - | -0.01 | -0.68 | 0.16 |
Other Non Operating Income (Expenses) | -0.13 | -0.18 | 0.38 | 0.36 | 0.21 | 0.67 |
EBT Excluding Unusual Items | -0.96 | -1.22 | -1.15 | -2.13 | -43.21 | -4.04 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 59.18 |
Legal Settlements | - | - | - | - | - | -19.46 |
Pretax Income | -0.96 | -1.22 | -1.15 | -2.13 | -43.21 | 35.68 |
Income Tax Expense | 5.72 | 5.72 | -2.49 | -1.76 | 0.96 | 1.83 |
Earnings From Continuing Operations | -6.68 | -6.94 | 1.34 | -0.37 | -44.17 | 33.86 |
Earnings From Discontinued Operations | 4.23 | 2.98 | -5.69 | - | - | - |
Net Income to Company | -2.44 | -3.97 | -4.35 | -0.37 | -44.17 | 33.86 |
Minority Interest in Earnings | - | - | - | - | - | 4.46 |
Net Income | -2.44 | -3.97 | -4.35 | -0.37 | -44.17 | 38.32 |
Net Income to Common | -2.44 | -3.97 | -4.35 | -0.37 | -44.17 | 38.32 |
Shares Outstanding (Basic) | 6 | 6 | 6 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 3 | 3 | 3 |
Shares Change (YoY) | -0.22% | - | 100.00% | 11.02% | 1.34% | 4.68% |
EPS (Basic) | -0.40 | -0.65 | -0.72 | -0.12 | -16.14 | 14.53 |
EPS (Diluted) | -0.40 | -0.65 | -0.72 | -0.21 | -16.17 | 14.28 |
Free Cash Flow | - | -4.45 | -2.75 | -2.82 | -4.88 | 29.81 |
Free Cash Flow Per Share | - | -0.73 | -0.45 | -0.93 | -1.78 | 11.04 |
Gross Margin | 82.41% | 82.71% | 83.03% | 80.64% | 81.52% | 86.41% |
Operating Margin | -5.88% | -7.77% | -13.03% | 14.83% | 6.18% | -55.17% |
Profit Margin | -17.93% | -30.06% | -35.70% | -1.14% | -171.60% | 133.11% |
Free Cash Flow Margin | - | -33.75% | -22.56% | -8.73% | -18.95% | 103.55% |
EBITDA | -0.63 | -0.84 | -1.35 | 4.99 | 1.78 | -15.6 |
EBITDA Margin | -4.65% | -6.38% | -11.04% | 15.49% | 6.91% | -54.20% |
D&A For EBITDA | 0.17 | 0.18 | 0.24 | 0.21 | 0.19 | 0.28 |
EBIT | -0.8 | -1.03 | -1.59 | 4.78 | 1.59 | -15.88 |
EBIT Margin | -5.88% | -7.77% | -13.03% | 14.83% | 6.18% | -55.17% |
Effective Tax Rate | - | - | - | - | - | 5.12% |